Skip to content

Clinical observation of shuitong and Shuijin points to inhibit sufentanil-induced cough

Clinical observation of shuitong and Shuijin points to inhibit sufentanil-induced cough

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005117
Enrollment
Unknown
Registered
2021-08-02
Start date
2021-08-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complications from sufentanil

Interventions

group D :2ml normal saline was injected intravenously before induction of anesthesia
group Z:acupuncture at shuitong point and Shuijin point before induction of anesthesia

Sponsors

Rizhao Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 85 Years

Inclusion criteria

Inclusion criteria: Heart and lung functions were normal, no history of drug abuse, no history of long-term use of opioids, and tolerance to surgical anesthesia.

Exclusion criteria

Exclusion criteria: Preoperative temperature > 38.5?, history of upper respiratory tract infection nearly 2 weeks before surgery,, chronic obstructive pulmonary disease, asthma, chest surgery, history of hypertension, smoking, use of hormones, bronchodilator drugs, vasoinvertase inhibitors

Design outcomes

Primary

MeasureTime frame
Choking cough cases;Severity of coughing;

Secondary

MeasureTime frame
Changes in hemodynamics;Number of chest wall stiffness cases;

Countries

China

Contacts

Public Contactxu jiping
rzhwfxjp@163.com13792045179

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026